Impact of a unified CT angiography system on outcome of patients with hepatocellular carcinoma

American Journal of Roentgenology

Volumn 192, Issue 3, 2009, Pages 766-774

  Toyoda, Hidenori ^a   Kumada, Takashi ^a   Sone, Yasuhiro ^a  

^a OGAKI MUNICIPAL HOSPITAL   (Japan)

Author keywords

Hepatocellular carcinoma; Survival; Transcatheter arterial chemoembolization; Tumor progression; Unified ct angiography system

Indexed keywords

IRON OXIDE;

AGED; ARTICLE; CANCER GROWTH; CANCER STAGING; CANCER SURVIVAL; CHEMOEMBOLIZATION; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SURVIVAL RATE;

AGED; ANGIOGRAPHY; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; CHI-SQUARE DISTRIBUTION; DISEASE PROGRESSION; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; STATISTICS, NONPARAMETRIC; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 63049115159     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/AJR.08.1368     Document Type: Article

References (35)

1. El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999; 340:745-750
2. El-Serag HB, Davila JA, Petersen NJ, McGlynn KA. The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update. Ann Intern Med 2003; 139:817-823
3. Toyoda H, Kumada T, Kiriyama S, et al. Changes in the characteristics and survival rate of hepatocellular carcinoma from 1976 to 2000: analysis of 1,365 patients in a single institution in Japan. Cancer 2004; 100:2415-2421
4. Matsui O, Kadoya M, Suzuki M, et al. Work in progress: dynamic sequential computed tomography during arterial portography in the detection of hepatic neoplasms. Radiology 1983; 146:721-727
5. Freeny PC, Marks WM. Computed tomographic arteriography of the liver. Radiology 1983; 148:193-197
6. Kanematsu M, Hoshi H, Murakami T, et al. Detection of hepatocellular carcinoma in patients with cirrhosis: MR imaging versus angiography assisted helical CT. AJR 1997; 169:1507-1515
7. Matsui O. Imaging of multistep human hepatocar-cinogenesis by CT during intra-arterial contrast injection. Intervirology 2004; 47:271-276
8. Kim SR, Ando K, Mita K, et al. Superiority of CT arterioportal angiography to contrast-enhanced CT and MRI in the diagnosis of hepatocellular carcinoma in nodules smaller than 2 cm. Oncology 2007; 72[suppl 1]:S58-S66
9. Inaba Y, Arai Y, Kanematsu M, et al. Revealing hepatic metastases from colorectal cancer: value of combined helical CT during arterial portography and CT hepatic arteriography with a unified CT and angiography system. AJR 2000; 174:955-961
10. Takayasu K, Muramatsu Y, Maeda T, et al. Targeted transarterial oily chemoembolization for small foci of hepatocellular carcinoma using a unified helical CT and angiography system: analysis of factors affecting local recurrence and survival rates. AJR 2001; 176:681-688
11. Torzilli G, Minagawa M, Takayama T, et al. Accurate preoperative evaluation of liver mass lesions without fine-needle biopsy. Hepatology 1999; 30:889-893
12. Kudo M. Imaging diagnosis of hepatocellular carcinoma and premalignant/borderline lesions. Semin Liver Dis 1999; 19:297-309
13. Liver Cancer Study Group of Japan. The general rules for the clinical and pathological study of primary liver cancer, 2nd English ed. Tokyo, Japan: Kanehara, 2003
14. Jang H-J, Lim JH, Lee SJ, Park CK, Park HS, Do YS. Hepatocellular carcinoma: are combined CT during arterial portography and CT hepatic arteriography in addition to triple-phase helical CT all necessary for preoperative evaluation? Radiology 2000; 215:373-380
15. Ueda K, Matsui O, Kawamori Y, et al. Hypervascular hepatocellular carcinoma: evaluation of hemodynamics with dynamic CT during hepatic arteriography. Radiology 1998; 206:161-166
16. Toyoda H, Kumada T, Kiriyama S, et al. Impact of surveillance on survival of patients with initial hepatocellular carcinoma: a study from Japan. Clin Gastroenterol Hepatol 2006; 4:1170-1176
17. Doyon DMA, Jourde AM, Regensberg C, Frileux C. Hepatic arterial embolization in patients with malignant liver tumors [in French]. Ann Radiol 1974; 17:593-603
18. Yamada R, Nakatsuka H, Nakamura K, et al. Transcatheter arterial embolization therapy in unresectable hepatomas: experience in 15 cases [in Japanese]. Acta Hepatologica Jpn 1979; 20:595-603
19. Konno T, Maeda H, Iwai K, et al. Effect of arterial administration of high-molecular-weight anti-cancer agent SMANCS with lipid lymphographic agent on hepatoma: a preliminary report. Eur J Cancer Clin Oncol 1983; 19:1053-1065
20. Ohishi H, Uchida H, Yoshimura H, et al. Hepatocellular carcinoma detected by iodized oil: use of anticancer agents. Radiology 1985; 154:25-29
21. Yumoto Y, Jinno K, Tokuyama K, et al. Hepatocellular carcinoma detected by iodized oil. Radiology 1985; 154:19-24
22. Takayasu K, Shima Y, Muramatsu Y, et al. Hepatocellular carcinoma: treatment with intraarterial iodized oil with and without chemotherapeutic agents. Radiology 1987; 163:345-351
23. Yoshikawa M, Saisho H, Ebara M, et al. A randomized trial of intrahepatic arterial infusion of 4′-epidoxorubicin with Lipiodol versus 4′-epidox-orubicin alone in the treatment of hepatocellular carcinoma. Cancer Chemother Pharmacol 1994; 33[suppl]:S149-S152
24. Sasaki Y, Imaoka S, Kasugai H, et al. A new approach to chemoembolization therapy for hepatoma using ethiodized oil, cisplatin, and gelatin sponge. Cancer 1987; 60:1194-1203
25. Kasugai H, Kojima J, Tatsuta M, et al. Treatment of hepatocellular carcinoma by transcatheter arterial embolization combined with intraarterial infusion of a mixture of cisplatin and ethiodized oil. Gastroenterology 1989; 97:965-971
26. Nakamura H, Hashimoto T, Oi H, Sawada S. Transcatheter oily chemoembolization of hepatocellular carcinoma. Radiology 1989; 170:783-786
27. Uchida H, Ohishi H, Matsuo N, et al. Transcatheter hepatic segmental arterial embolization using lipiodol mixed with an anticancer drug and Gel-foam particles for hepatocellular carcinoma. Cardiovasc Intervent Radiol 1990; 13:140-145
28. Matsui O, Kadoya M, Yoshikawa J, et al. Small hepatocellular carcinoma: treatment with subsegmental transcatheter arterial embolization. Radiology 1993; 188:79-83
29. Chang JM, Tzeng WS, Pan HB, Yang CF, Lai KH. Transcatheter arterial embolization with or without cisplatin treatment of hepatocellular carcinoma: a randomized controlled study. Cancer 1994; 74:2449-2453
30. Lin DY, Liaw YF, Lee TY, Lai CM. Hepatic arterial embolization in patients with resectable hepatocellular carcinoma: a randomized controlled trial. Gastroenterology 1988; 94:453-456
31. Groupe d'Etude et de Traitement du Carcinome Hepatocellulaire. A comparison of lipiodol chemoembolization and conservative treatment of unresectable hepatocellular carcinoma. N Engl J Med 1995; 332:1256-1261
32. Bruix J, Llovet JM, Castells A, et al. Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: results of a randomized controlled trial in a single institution. Hepatology 1998; 27:1578-1583
33. Pelletier G, Ducreux M, Gay F, et al. Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization: a multicenter randomized trial - Groupe CHC. J Hepatol 1998; 29: 129-134
34. Llovet JM, Real MI, Montana X, et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 2002; 359:1734-1739
35. Lo CM, Ngan H, Tso WK, et al. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 2002; 35:1164-1171